Innovation
Innovación
12
Feb
2024
€2.7 million to begin Phase IIa trials for CTH120 in Fragile X syndrome
The Spanish Ministry of Science and Innovation back joint project by Connecta Therapeutics, the CRG, IMIM and I3PT
08
Feb
2024
CRG and Almirall partner to identify new biomarkers for atopic dermatitis treatments
The Proteomics Unit will work with Almirall to create advanced disease models
17
Oct
2023
“la Caixa” Foundation Backs Efforts to Validate New Therapeutic Targets for Breast Cancer
Dr. Isabelle Vernos’ to receive €50,000 to validate possible treatment for breast cancer
07
Jun
2023
Unleashing splicing to understand biology and eventually tackle ‘untreatable’ diseases
Cells use editing tools to skip or rearrange information stored in DNA. A 10-million-euro ERC Synergy Grant will explore how to control this process with molecular precision.
26
Abr
2023
Cancer cell ‘decathlon’ to help predict tumour aggressiveness and metastasis
A European Innovation Council-funded project aims to quantify a cancer cell’s plasticity
17
Dic
2020
Resuscitating eyes to speed up clinical research for vision impairment
The new method will help researchers assess the efficacy, efficiency, and safety of new regenerative therapies and drug testing for eyesight loss
08
Sep
2020
Viral Beacon: A beacon in the ocean of SARS-CoV-2 data
An ELIXIR Spain platform allows researchers to browse SARS-CoV-2 variability at the genome, amino acid, structural and motif level
The Spanish Ministry of Science and Innovation back joint project by Connecta Therapeutics, the CRG, IMIM and I3PT
The Proteomics Unit will work with Almirall to create advanced disease models
Dr. Isabelle Vernos’ to receive €50,000 to validate possible treatment for breast cancer
Cells use editing tools to skip or rearrange information stored in DNA. A 10-million-euro ERC Synergy Grant will explore how to control this process with molecular precision.
A European Innovation Council-funded project aims to quantify a cancer cell’s plasticity
The new method will help researchers assess the efficacy, efficiency, and safety of new regenerative therapies and drug testing for eyesight loss
An ELIXIR Spain platform allows researchers to browse SARS-CoV-2 variability at the genome, amino acid, structural and motif level